1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Blood Pressure, Low in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, RS; Bodey, GP; Burgess, MA; Leavens, M; Stewart, DJ; Valdivieso, M | 1 |
1 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Blood Pressure, Low
| Article | Year |
|---|---|
Phase I study of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466) in adults with solid tumors.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Brain Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Glioblastoma; Glioma; Humans; Hypotension; Male; Middle Aged; Mustard Compounds; Nausea; Neoplasms; Nitrosourea Compounds; Thrombocytopenia | 1980 |